retrospective review NUMBER evaluable patients treated radiation therapy mediastinum stages ii hodgkins disease eligible patients receiving NUMBER rad mediastinum chemotherapy prior radiation study period NUMBER patients developed symptomatic pericarditis interval post treatment development symptoms NUMBER months incidence pericarditis studied function NUMBER dose radiation depth NUMBER cm NUMBER cm midplane mediastinum NUMBER ratio anterior posterior weighting dose NUMBER presence absence intrathoracic tumor NUMBER size tumor present NUMBER fraction heart exposed radiation beam significant increase incidence pericarditis increased dose radiation NUMBER cm NUMBER cm midplane depths presence large intrathoracic tumor reduction mediastinal dose recommended iii